TREM1 and rheumatoid arthritis: In contrast to Gamez-Nava et al.48, who failed to identify differences in serum TREM-1 levels relative to MTX use, our findings demonstrated significantly decreased serum TREM-1 levels in RA patients on MTX as compared to those on other csDMARDs.